SPS
IRON icon

Susquehanna Portfolio Strategies’s Disc Medicine IRON Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$425K Buy
+5,808
New +$399K 0.01% 690
2026
Q1 		– Sell
-3,733
Closed -$296K – 1038
2025
Q4 		$296K Hold
3,733
– – ﹤0.01% 881
2025
Q3 		$247K Buy
+3,733
New +$222K ﹤0.01% 950

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Susquehanna Portfolio Strategies's IRON Position: Q2 2026 in Review

Susquehanna Portfolio Strategies opened a new position in Disc Medicine (IRON) in Q2 2026: 5,808 shares worth $425K. The stake represents 0.01% of the portfolio and ranks #690 among its holdings. This is a return to the name: Susquehanna Portfolio Strategies previously reported a position in IRON as recently as Q4 2025.

Susquehanna Portfolio Strategies first reported a position in IRON in Q3 2025 and has held it in 3 quarters since. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Susquehanna Portfolio Strategies held 5,808 shares of Disc Medicine worth $425K as of Q2 2026.
  • Disc Medicine was a new Susquehanna Portfolio Strategies position in Q2 2026.
  • Disc Medicine made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #690 holding.
  • Susquehanna Portfolio Strategies first reported a position in Disc Medicine in Q3 2025 and has held it in 3 quarters since.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.